David Kirk Selected Research

meta-((211)At)astatobenzylguanidine

11/2005

Comparison of radiohaloanalogues of meta-iodobenzylguanidine (MIBG) for a combined gene- and targeted radiotherapy approach to bladder carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

David Kirk Research Topics

Disease

2	Prostatic Neoplasms (Prostate Cancer) 12/2010 - 02/2002
2	Urinary Bladder Neoplasms (Bladder Cancer) 11/2005 - 02/2005
1	Immune System Diseases (Immune Disorders) 07/2015
1	Breast Neoplasms (Breast Cancer) 01/2007
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2006
1	Organizing Pneumonia 12/2006
1	Bronchiolitis Obliterans 12/2006
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 11/2005
1	Carcinoma (Carcinomatosis) 11/2005
1	Transitional Cell Carcinoma 02/2005
1	Stroke (Strokes) 07/2004
1	Ischemia 07/2004

Drug/Important Bio-Agent (IBA)

2	3-Iodobenzylguanidine (Iobenguane)IBA 11/2005 - 02/2005
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2005 - 02/2005
2	N-acetyltalosaminuronic acid (NAT)IBA 11/2005 - 02/2005
2	Norepinephrine Plasma Membrane Transport Proteins (Norepinephrine Transporter)IBA 11/2005 - 02/2005
1	Rituximab (Mabthera)FDA Link 12/2006
1	Monoclonal AntibodiesIBA 12/2006
1	salicylhydroxamic acid (SHAM)IBA 11/2005
1	meta-((211)At)astatobenzylguanidineIBA 11/2005
1	Pharmaceutical PreparationsIBA 02/2005
1	Radioisotopes (Radionuclides)IBA 02/2005
1	Contrast MediaIBA 07/2004
1	Gadolinium DTPA (Magnevist)FDA Link 07/2004
1	E-SelectinIBA 07/2004
1	Sialyl Lewis X AntigenIBA 07/2004
1	AndrogensIBA 02/2002

Therapy/Procedure

3	Therapeutics 07/2015 - 11/2005
2	Radiotherapy 11/2005 - 02/2005
1	Chemoprevention 12/2010
1	Resistance Training 01/2007